Ads
    Related conference
  1. Hormone resistance in non-atypical endometrial hyperplasia: role of PgR-A and PgR-B expression in predicting treatment response
  2. Molecular mechanisms of resistance of endometrial hyperplasia to progestogen therapy based on the study of the expression of estrogen and progesterone receptors and paracrine cellular markers of cellular interaction
  3. Clinical-immunohistochemical characteristics of atypical endometrial hyperplasia in women of reproductive age
  4. HOW MANY PREGNANCIES ARE ALLOWED AFTER FERTILITY PRESERVING MANAGEMENT OF ATYPICAL ENDOMETRIAL HYPERPLASIA?
  5. Achievements and prospects of therapy for non-atypical endometrial hyperplasia in reproductive-aged women
  6. Development of a model for prediction of relaxation and progression of hormone-resistant form of endometrial hyperplasia in women of reproductive age
  7. Endometrial hyperplasia and progesterone resistance: a complex relationship
  8. NEW ASPECTS OF ENDOMETRIAL HYPERPLASIA TREATMENT
  9. Current approaches to the treatment of endometrial hyperplasia in women with uterine leiomyoma
  10. ENDOMETRIAL HYPERPLASIA IN WOMEN OF REPRODUCTIVE AGE: CLINICAL FEATURES, DIAGNOSIS, PATHOGENESIS AND TREATMENT